Life sci­ences fund rais­es €118M for its next round of bets; Gilead scraps Alpine al­liance

→ A small but grow­ing transat­lantic biotech in­vestor is get­ting a fresh shot in the arm for its next round of bets. Foun­tain Health­care Part­ners has raised €118 mil­lion for Fund III, bring­ing its to­tal amount of cap­i­tal raised to €294 mil­lion. The fund has of­fices in Dublin and New York, with plans to in­vest the bulk of its mon­ey in Eu­rope, with part of the port­fo­lio in the US. “Foun­tain’s in­vest­ment strat­e­gy fo­cus­es on build­ing a bal­anced port­fo­lio of com­pa­nies with com­ple­men­tary risk and re­turn pro­files with­in the life sci­ence sec­tor,” not­ed co-founder Manus Ro­gan.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER